Actively Recruiting
Study of an Electronic Alert System to Increase Use of Cholesterol-Lowering Medicines in Adults with Peripheral Artery Disease Not Currently Treated
Led by Brigham and Women's Hospital · Updated on 2026-06-17
400
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the use of an alert-based computerized decision support tool called the EPIC Best Practice Advisory BPA to improve the prescription of guideline-recommended cholesterol-lowering medications for patients with peripheral artery disease PAD who are not currently receiving such therapy. This randomized controlled trial involves 400 patients and aims to address underutilization of LDL-C-lowering treatments due to factors like clinician knowledge gaps, provider inertia, and statin intolerance. Participants will be randomly assigned to one of two groups. The experimental group will have clinicians receive an on-screen electronic alert notifying them that the patient with PAD is not prescribed LDL-C-lowering therapy, offering options to order treatment or review current guidelines. The comparison group will have no alert notifications. This approach evaluates whether the alert increases the frequency of appropriate statin or alternative oral LDL-C-lowering prescriptions. Throughout the study, researchers will monitor how often oral LDL-C-lowering therapy is prescribed within 90 days and measure changes in LDL cholesterol levels over six months. Participants are patients aged 18 and older seen in specified clinics with PAD who are not on LDL-C-lowering therapy. Data collection will include medical histories, diagnoses, and prescription records to assess the impact of the alert system on treatment adherence and lipid levels.
CONDITIONS
Brief Title
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
Research Team
G
Gregory Piazza
C
Candrika D Kharaini
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here